HIM
INSM icon

Hillsdale Investment Management’s Insmed INSM Stock Holding History

Hillsdale Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,700
Closed -$6.15M – 711
2025
Q3 		$6.15M Sell
42,700
-7,000
-14% -$858K 0.19% 163
2025
Q2 		$5M Sell
49,700
-2,200
-4% -$168K 0.18% 167
2025
Q1 		$3.96M Sell
51,900
-5,100
-9% -$390K 0.2% 114
2024
Q4 		$3.94M Buy
57,000
+300
+0.5% +$21.6K 0.2% 136
2024
Q3 		$4.14M Buy
56,700
+100
+0.2% +$7.38K 0.32% 103
2024
Q2 		$3.79M Buy
+56,600
New +$2.2M 0.3% 117
2019
Q4 		– Sell
-28,900
Closed -$510K – 619
2019
Q3 		$510K Hold
28,900
– – 0.04% 337
2019
Q2 		$740K Buy
+28,900
New +$805K 0.07% 261

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Hillsdale Investment Management's INSM Position: Q4 2025 in Review

Hillsdale Investment Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 42,700 shares — an estimated $6.15M sold.

Hillsdale Investment Management first reported a position in INSM in Q2 2019 and held it in 8 quarters. The position peaked at $6.15M in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Hillsdale Investment Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 42,700 Insmed shares in Q4 2025, an estimated $6.15M.
  • Hillsdale Investment Management first reported a position in Insmed in Q2 2019 and held it in 8 quarters.
  • Hillsdale Investment Management's Insmed position peaked at $6.15M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Hillsdale Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.